About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
The non-partisan Congressional Budget Office (CBO) released a new report stating 340B increases health care costs in the U.S. and includes no evidence that patients benefit. Markups from the program contribute nearly $65 billion to drug spending, benefiting hospitals and clinics rather than patients. This cost burden increases drug expenses for the government and Americans nationwide.
The 340B Hospital Markup Program is Costing Taxpayers & Employers Billions teaser
Fact Sheet
340B
The 340B Hospital Markup Program is Costing Taxpayers & Employers Billions
The 340B Hospital Markup Program is Costing Taxpayers & Employers Billions teaser